Jeremy Carlosama | Biomedical Engineering | Research Excellence Award

Published on by Popular Engineer

Mr. Jeremy Carlosama | Biomedical Engineering | Research Excellence Award

Yachay Tech University | Ecuador

Jeremy Fabrizio Carlosama Quinatoa is an emerging researcher in biomedical engineering whose work focuses on applying machine learning and intelligent sensing technologies to healthcare and rehabilitation. He holds a degree in Biomedical Engineering from Yachay Tech University, where his academic training emphasized biomechanics, human motion analysis, and data-driven medical systems. His professional experience includes teaching and research activities in biomechanics and biomedical signal processing, as well as participation in interdisciplinary projects that integrate inertial sensors, motion capture systems, neural networks, and clinical data. His research interests span machine learning for healthcare, rehabilitation engineering, inertial sensor systems, neural-network-based medical diagnosis, and assistive technologies. He has authored peer-reviewed research outputs including a journal article in Sensors (MDPI) and international conference book chapters addressing low back pain assessment, sign-language recognition, and heart failure diagnosis using artificial intelligence. As of 2025, his scholarly record includes 4 publications, an h-index of 2, and over 30 citations, reflecting growing academic impact at an early career stage. His work demonstrates a strong commitment to translational research that bridges engineering innovation and clinical application, positioning him as a promising young scientist contributing to the advancement of intelligent healthcare technologies.

Citation Metrics (Google Scholar)

1200
1000
600
200
0

Citations
2
Documents
0
h-index
1

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications

Ecuadorian Sign Language Detection in Real Time

J. Carlosama, S. Criollo, C. Játiva, V. Mina, S. Velastegui, J. de-la-A, et al.
International Conference on Computer Science, Electronics and Industrial Engineering, 2023

InertialMov: Machine Learning Test Based on Inertial Sensors to Predict Mobility Impairment in Low Back Pain Patients

J. Carlosama, L. Zhinin-Vera, C. Guevara, C. Cadena-Morejón, et al.
Sensors, Vol. 25(21), Article 6665, 2025

Diagnosis of Heart Failure: Integrating Echocardiographic and Clinical Data Through Neural Networks

V. Arrobo-Sarango, J. Carlosama, D. Almeida-Galárraga, A. Tirado-Espín, et al.
International Conference on Smart Technologies, Systems and Applications, 2024

Mario Schiffer | Biology and Life Sciences | Best Researcher Award

Published on by Popular Engineer

Prof. Dr. Mario Schiffer | Biology and Life Sciences | Best Researcher Award

Erlangen University Hospital Department of Medicine 4 Nephrology and Hypertension | Germany

A leading figure in nephrology research, this scholar has built a distinguished career advancing the molecular understanding of proteinuria, glomerular diseases. Trained in molecular biology, internal medicine, and nephrology across top institutions, his academic journey spans medical education, residency, postdoctoral research in proteinuria, and progressive academic appointments culminating in a full professorship and departmental leadership. His research interests include podocyte biology, TGF-β and BMP signaling, nephrin turnover, slit diaphragm dynamics, zebrafish-based high-throughput screening, and mechanisms underlying diabetic and inflammatory kidney disease. He pioneered assays to study proteinuria in zebrafish, contributed to defining pathways of podocyte apoptosis, and advanced translational strategies linking basic science to clinical interventions in transplant nephrology. His work has been recognized with major honors such as the Heisenberg Professorship, New Investigator Awards, Franz Volhard Award, and multiple grants from leading scientific foundations. With extensive experience in clinical nephrology, scientific leadership roles, and multidisciplinary collaborations, he continues to drive innovation in kidney disease research and therapeutic development.

Profile : Orcid

Featured Publications

Bolanos‐Palmieri, P., Schenk, H., Bähre, H., Schroder, P., Staggs, L., Haller, H., & Schiffer, M. (2025). Kynurenine pathway dysregulation impairs podocyte morphology and bioenergetics in vitro and leads to glomerular dysfunction. The FASEB Journal.

Boi, R., Lassén, E., Johansson, A., Liu, P., Chaudhari, A., Tati, R., Müller-Deile, J., Schiffer, M., Ebefors, K., & Nyström, J. (2025). Cytoskeleton-associated protein 4 affects podocyte cytoskeleton dynamics in diabetic kidney disease. JCI Insight.

Bihlmaier, K., Willam, C., Herbst, L., Hackstein, H., Schiffer, M., Ströbel, A. M., Achenbach, S., Grampp, S., Bujok, K., Büstgens, F., et al. (2025). Rapid clinical effects of convalescent plasma therapy in severe COVID-19 acute respiratory distress syndrome (ARDS). Intensive Care Medicine.

Fueermann, F., Heller, K., Pavel, M., Herbst, L., Grützmann, R., & Schiffer, M. (2024). Pancreas transplantation as rescue therapy in a patient with type 1 diabetes and concurrent subcutaneous insulin resist.

Kraus, A., Skoczynski, K., Brötsch, M., Burzlaff, N., Leipziger, J., Schiffer, M., Büttner-Herold, M., & Buchholz, B. (2024). P2Y2R and cyst growth in polycystic kidney disease. Journal of the American Society of Nephrology.

Ana Maria Abreu Velez | Medicine and Health Sciences | Best Researcher Award

Published on by Popular Engineer

Dr. Ana Maria Abreu Velez | Medicine and Health Sciences | Best Researcher Award

Georgia Dermatopathology Associates | United States

Dr. Ana María Abreu Vélez, M.D., Ph.D., DSc, is a globally recognized dermatologist, immunohematologist, and biomedical researcher renowned for her leadership in autoimmune orphan diseases and multidisciplinary clinical research. With an impactful scholarly record including 72peer-reviewed publications, an h-index of 14, 659 citations. she has advanced scientific understanding across dermatology, immunology, toxicology, and tropical medicine. Her academic path includes a medical degree, a Doctorate in Science, and multiple postdoctoral fellowships spanning immunohematology, dermatopathology, and translational research. She has served in senior scientific and operational leadership roles, driving innovation, improving surveillance systems, and modernizing data-driven healthcare programs in national and international settings. Her research focuses on autoimmune blistering diseases, environmental toxicants, clinical trials, infectious diseases, and precision diagnostics. Her career includes leading major healthcare programs, enhancing operational efficiency, reducing costs, mentoring multidisciplinary teams, and developing novel scientific frameworks. Widely respected for her analytical rigor and scientific contributions, Dr. Abreu continues to advance global health through research excellence, strategic leadership, and impactful biomedical innovation.

Profiles : Scopus | Orcid

Featured Publications

Abreu Velez, A. M., Ramirez-Posada, M., & Howard, M. S. (2025). Post translational modifications and protein-protein interactome of endemic pemphigus in El Bagre, Colombia: A new variant analysis. Dermatology Practical & Conceptual, 15(3).

Abreu-Velez, A. M., Ramos Muñoz, W., & Howard, M. (2025). Is Tunisian endemic pemphigus foliaceus a real entity or should these cases be reclassified with other autoimmune blistering diseases? Dermatology Practical & Conceptual, 15(2).

Abreu Velez, A. M., Hashimoto, T., Upegui, Y. A., Vélez Arango, J. M., Olarte Aponte, A. M., Vega, J. A., & Howard, M. S. (2025). The pericardium cells junctions are a target for autoantibodies of patients affected by a variant of endemic pemphigus foliaceus in El Bagre and surrounding municipalities in Colombia, South America. Diagnostics, 15(8).

Abreu Velez, A. M., Hashimoto, T., Vélez Arango, J. M., Upegui‐Zapata, Y. A., Upegui‐Quiceño, E., Olarte Aponte, A. M., & Howard, M. S. (2025). New complex cell junctions in and around the intervertebral discs discovered using autoantibodies from patients affected by endemic pemphigus foliaceus in El Bagre, Colombia, South America. International Journal of Dermatology, 64(3).

Abreu Velez, A. M., Ramírez‐Posada, M., & Howard, M. S. (2024). Immunofluorescence findings in a reactivating lichenoid photoallergic chronic dermatitis (actinic reticuloid). Photodermatology, Photoimmunology & Photomedicine, 40(5).

Milad Shirvaliloo | Genetics and Genomics | Best Researcher Award

Published on by Popular Engineer

Dr. Milad Shirvaliloo | Genetics and Genomics | Best Researcher Award

Iran University of Medical Sciences | Iran

Milad Shirvaliloo holds an MD and an MBA in Health Sciences and is an aspiring physician-researcher with over six years of investigative experience in epigenetics, cancer biology and pulmonary medicine. He has published more than 40 peer-reviewed articles and a book chapter, and serves on the Editorial Board of Epigenomics and as reviewer for 60+ Web of Science-indexed journals. His academic journey includes medical education at Tabriz University of Medical Sciences and postgraduate research at Iran University of Medical Sciences  focusing on nanoparticle-based therapeutic interventions and histone acetylation in cancer. His work spans diagnostics (e.g., nano-biosensor assays for SARS-CoV-2), lung epithelium development (epigenetic cues in human lung organoids) and cancer nano-theranostics (targeted magnetochemotherapy and histone modification mapping). According to h-index is 16 and he has amassed over 819 citations to date. His main research interests include histone modifications, chromatin accessibility, nanoparticle-mediated drug delivery and epigenetic biomarkers in respiratory and oncologic diseases. He brings strong skills in scientific communication, evidence synthesis, statistical & bioinformatics analysis and R programming. In conclusion, Milad’s interdisciplinary expertise positions him at the interface of molecular epigenetics and translational nanomedicine with the aim to advance precision diagnostics and therapies.

Profiles : Scopus | Google Scholar 

Featured Publications

Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & Youshanlouei, H. R., et al. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.

Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & Pilehvar-Soltanahmadi, Y., et al. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.

Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.

Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & Sheervalilou, R., et al. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.

Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & Fathi-Karkan, S., et al. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.

Mir Ahmad | Medicine and Health Sciences | Best Researcher Award

Published on by Popular Engineer

Dr. Mir Ahmad | Medicine and Health Sciences | Best Researcher Award

Government Medical College, Doda, Jammu and Kashmir | India

Dr. Mir Kaisar Ahmad (PhD Biochemistry) serves as Assistant Professor and Head of the Department of Biochemistry at the Faculty of Medicine, Government Medical College (Doda), Jammu & Kashmir, India. He holds an M.Sc. in Biochemistry and a PhD from Aligarh Muslim University, India, and a B.Sc. from the University of Kashmir. His earlier roles include Tutor/Demonstrator in Biochemistry at GMC Baramulla, Senior Resident in Clinical Biochemistry at Sher-i-Kashmir Institute of Medical Sciences, Srinagar, and Assistant Professor (Guest Faculty) at AMU’s Faculty of Life Sciences. His research focuses on oxidative stress, antioxidant therapy and toxicological biochemistry particularly the effects of potassium bromate and protective dietary agents such as taurine and vitamin C. Dr. Ahmad mentors postgraduate research and leads outreach efforts such as health screening camps. His commitment to bridging clinical biochemistry and toxicology exemplifies his role as an educator-scientist driving translational research in the Jammu & Kashmir region.

Profile : Google Scholar

Featured Publications

Datir, A., James, S. L. J., Ali, K., Lee, J., Ahmad, M., & Saifuddin, A. (2008). MRI of soft-tissue masses: The relationship between lesion size, depth, and diagnosis. Clinical Radiology, 63(4), 373–378.

Ahmad, M. K., Khan, A. A., Ali, S. N., & Mahmood, R. (2015). Chemoprotective effect of taurine on potassium bromate-induced DNA damage, DNA–protein cross-linking and oxidative stress in rat intestine. PLOS ONE, 10(3), e0119137.

Imran, Z., Rafiq, M. A., Ahmad, M., Rasool, K., Batool, S. S., & Hasan, M. M. (2013). Temperature dependent transport and dielectric properties of cadmium titanate nanofiber mats. AIP Advances, 3(3), 032121.

Zafar, A. H., Ahmad, M., & Rehman, S. U. (2008). Study of some performance traits in Sahiwal cows during different periods. Pakistan Veterinary Journal, 28(2), 84–88.

Ahmad, M. K., Amani, S., & Mahmood, R. (2011). Potassium bromate causes cell lysis and induces oxidative stress in human erythrocytes. Environmental Toxicology, 26(3), 250–257.

Marwa Hassan | Molecular Biology | Best Researcher Award

Published on by Popular Engineer

Assist. Prof. Dr. Marwa Hassan | Molecular Biology | Best Researcher Award

Theodor Bilharz Research Institute | Egypt

Marwa Hassan is an immunologist with substantive contributions in stem cell biology, molecular immunology, and translational research. She also holds a Postgraduate Diploma in Healthcare & Hospital Management (American University in Cairo, 2020). Over her career she has held roles from resident researcher to acting head of department at the Immunology Division of TBRI, and has organized and led numerous specialized training courses (e.g. stem cell culture, molecular immunology, ELISA). Her research interests include non-coding RNAs, stem cell differentiation, immune regulation in liver disease, and biomarker development. She has published in peer-reviewed journals (e.g. on circulating liver cancer stem cells) and contributed to capacity building via workshops and academic leadership. Her awards and recognitions reflect her dual strengths in research and academic service. In sum, Dr. Hassan combines rigorous scientific inquiry with institutional leadership, advancing immunology and regenerative medicine in Egypt and beyond.

Profile : Orcid

Featured Publications

Ahmed, M. H. M., & Abdel Hamid, H. M. (2022). Circulating liver cancer stem cells: Clinical implications and future perspectives. World Journal of Gastroenterology, 28(1), 39–52

Ahmed, M. H. M., El Refai, S., & El-Shenawy, R. (2021). MicroRNA-based biomarkers in hepatitis C virus-induced hepatocellular carcinoma. Egyptian Journal of Immunology, 28(2), 75–90.

Ahmed, M. H. M., Hussein, M., & El Sayed, A. (2020). Impact of mesenchymal stem cell passaging on proliferation and differentiation potential. Theodor Bilharz Medical Journal, 18(4), 201–210.

Ahmed, M. H. M., Ibrahim, N., & Khalifa, M. (2019). Role of regulatory T-cells in autoimmune liver diseases: An immunopathological study. Journal of Clinical and Experimental Hepatology, 9(3), 355–362.

Ahmed, M. H. M., & El Demerdash, R. (2017). Gene expression profiling of umbilical cord blood-derived mesenchymal stem cells under oxidative stress. Stem Cell Research & Therapy, 8(1), 112.

Ehsan Khedre | Biology and Life Sciences | Best Researcher Award

Published on by Popular Engineer

Dr. Ehsan Khedre | Biology and Life Sciences | Best Researcher Award

Egyptian Drug Authority Pyramids Branch | Egypt

Dr. Ehsan Khedre is a pharmaceutical biochemistry researcher whose work spans natural product pharmacology, nanotechnology, oxidative stress, and metabolic disease. After earning her B.Pharm (Ain-Shams University, Egypt, 2004), she completed an M.Sc. in Biochemistry (Zagazig University, 2011) and a Ph.D. (Al-Azhar University, 2018) on estrogenic effects of quercetin and its nanoparticles. She has held roles at Egypt’s National Organization for Drug Control & Research (NODCAR / EDA), advancing from drug control specialist to quality manager and researcher in biochemical laboratories. Her publication record (to date > 9 peer-reviewed articles) includes studies on hepatic fibrosis, nanocarrier enhancement of phytochemicals, metabolic syndrome models, and nanoparticle biodistribution. Her citation metrics h-index of 5, total documents 7, total citations 170 reflect her growing impact in pharmacology and toxicology. Her research interests include antioxidant and anti-inflammatory natural compounds, nanoparticle delivery systems, biochemical mechanisms of organ injury, and translational approaches to metabolic and hepatic diseases. She has also contributed by serving as reviewer for journals, receiving training in quality systems (ISO 9001 / ISO 17025), scientific writing, bioinformatics, and innovation, and participating in workshops on research skills. In sum, Dr. Khedre combines deep domain expertise, laboratory leadership, and interdisciplinary scholarship to advance discovery and application of therapeutics.

Profiles : Orcid | Scopus

Featured Publications

Fayed, E. A., El-Sebaey, S. A., Ebrahim, M. A., Abu-Elfotuh, K., El-Sayed Mansour, R., Mohamed, E. K., Hamdan, A. M. E., Al-subaie, F. T., Albalawi, G. S., Albalawi, T. M., et al. (2025). Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BChE inhibitors, in-vivo and in-vitro assays, ADMET and molecular docking simulation. European Journal of Medicinal Chemistry, 117201.

Abu-Elfotuh, K., Kamel, G. A. M., Najm, M. A. A., Hamdan, A. M. E., Koullah, M. T., Fahmy, R. K. E., Aboelsoud, H. A., Alghusn, M. A., Albalawi, B. R., Atwa, A. M., et al. (2025). Modulating multiple molecular trajectories by nutraceuticals and/or physical activity in attention-deficit/hyperactivity disorder (ADHD)-like behaviors in rat pups. Journal of NeuroImmune Pharmacology.

Oudah, K. H., Najm, M. A. A., Ramsis, T. M., Ebrahim, M. A., Gohar, N. A., Abu-Elfotuh, K., Mohamed, E. K., Hamdan, A. M. E., Hamdan, A. M., Almotairi, R., et al. (2025). Unlocking therapeutic potential of novel thieno-oxazepine hybrids as multi-target inhibitors of AChE/BChE and evaluation against Alzheimer’s disease: In vivo, in vitro, histopathological, and docking studies. Pharmaceuticals, 18(8), 1214.

Nazeam, J. A., Black, I., Mulamoottil, V. A., Selim, N. M., El Shiekh, R. A., Abu-Elfotuh, K., Hamdan, A. M. E., Gowifel, A. M. H., Hafez, S. M., Mohamed, E. K., et al. (2025). Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes. International Immunopharmacology, 114110.

Mohamed, E. K., Fathy, M. M., Sadek, N. A., & Eldosoki, D. E. (2024). The effects of rutin coat on the biodistribution and toxicities of iron oxide nanoparticles in rats. Journal of Nanoparticle Research, 26(3), 49.

Konstantinos Zapsalis | Medicine and Health Sciences | Best Academic Researcher Award

Published on by Popular Engineer

Mr. Konstantinos Zapsalis | Medicine and Health Sciences | Best Academic Researcher Award

Aristotle University of Thessaloniki (AUTH) | Greece

Dr. Konstantinos Zapsalis is a PhD candidate at Aristotle University of Thessaloniki, focusing his research on abdominal wall reconstruction using platelet-rich plasma and adipose tissue micrografts. He holds an MSc in Surgical Oncology of the GI tract with distinction and a medical degree from the same institution. With extensive clinical experience across leading hospitals in Greece and the UK, including Epsom and St. Helier Hospital NHS and St. George’s University Hospital, he has been actively involved in general and vascular surgery, emergency surgery, and trauma care. His research contributions are notable, over 196 citations, an h-index of 8, and more than 25 research documents addressing regenerative surgery, wound healing, surgical oncology, and minimally invasive procedures. He has presented at international congresses such as the World Society of Emergency Surgery and Panhellenic Surgical Congresses, earning recognition for his innovative work, including praise at the 33rd Panhellenic Surgical Congress for his study on the use of ICG in pancreatic surgery. His teaching experience includes instructing medical students and leading surgical skills workshops, while his leadership roles in scientific societies highlight his commitment to academic advancement. With strong clinical, academic, and research credentials, Dr. Zapsalis represents a promising surgeon-scientist contributing to translational surgical innovation.

Profile : Scopus

Featured Publications

“Platelet rich plasma, adipose tissue micrografts, and regenerative mimetic factors for abdominal wall defect   reconstruction: Experimental study protocol”

“Tailored Negative Pressure Wound Therapy with instillation in diabetic, hypertensive, and obese patients when   guideline treatment is not enough: a case series and a proposal for the ANSWER score”

“A Comprehensive Review of the Impact of Platelet Concentrates on Mesh Integration in Hernia Management”

“Patterns of opioid use after surgical discharge: a multicentre, prospective cohort study in 25 countries”

“Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition”

Michel Stéphane Heya | Medicine and Health Sciences | Best Review Paper Award

Published on by Popular Engineer

Assoc. Prof. Dr. Michel Stéphane Heya | Medicine and Health Sciences | Best Review Paper Award

 Universidad Autónoma de Nuevo León | Mexico

Dr. Michel Stéphane Heya is a distinguished researcher and professor specializing in biotechnology, with a Ph.D. from the Institute of Biotechnology, Universidad Autónoma de Nuevo León, Mexico. As a member of the National System of Researchers and Investigators (SNII), he has contributed extensively to the bioprospecting of green alternatives for human health and the development of nanomedicines for controlled pharmacological delivery. His work spans nephroprotective, antifungal, antibacterial, and anticancer applications, employing natural compounds, polymeric nanoparticles, and exosome-based nanocarriers. Dr. Heya has published over 50 scientific articles and book chapters in high-impact journals, accumulating more than 127 citations, with an h-index of 4. His ongoing research focuses on integrating traditional medicine with advanced nanotechnologies to enhance therapeutic efficacy and sustainability. Recognized for his innovative approaches to green nanomedicine, Dr. Heya continues to expand interdisciplinary research, training the next generation of scientists, and promoting environmentally friendly biomedical solutions. His work demonstrates a commitment to advancing health sciences while fostering sustainable and translational research applications.

Profile : Google scholar

Featured Publications

“In Vitro Antifungal Antibacterial Activity of Partitions from Euphorbia tirucalli”

“Diagnóstico de la tinea pedis y tinea unguium en la zona metropolitana de Monterrey, Nuevo León, México”

“Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using Nanotechnology”

“Plasma Antioxidant Capacity Is Related to Dietary Intake, Body Composition, and Stage of Reproductive Aging in   Women”

“In vitro antifungal activity of polymeric nanoparticles loaded with Euphorbia tirucalli extract”

Yan Ding | Biology and Life Sciences | Excellence in Research

Published on by Popular Engineer

Prof. Yan Ding | Biology and Life Sciences | Excellence in Research

China Medical University | China

Dr. Yan Ding is a biomedical researcher with a doctorate from China Medical University, Shenyang. Her academic training includes a Bachelor’s degree from Shenyang Pharmaceutical University, a Master’s and PhD from China Medical University. Since 2013, she has progressed through roles in experimental research—assistant experimentalist, experimentalist, and since 2022, senior experimentalist—at the Institute of Metabolic Disease Research & Drug Development and the College of Basic Medical Science. Her research focuses on molecular and cellular mechanisms underlying lung injury, inflammation, epithelial sodium transport, miRNA regulation, pulmonary fibrosis and herbal / natural compounds’ effects. She has published numerous first-author papers addressing roles of miRNAs (e.g. miR-130a-3p, miR-199a-3p, miR-21), luteolin’s therapeutic potential, regulation of epithelial sodium channel (ENaC), anti-oxidant and anti-inflammatory pathways. she has an h-index of 6 with 143 citations overall. Throughout her career, she has also contributed to studies of lung fluid clearance, regulatory mechanisms during viral infections, and herbal monomers in edematous disorders. Awards include recognition for excellence in experimental work (institutional). In conclusion, Dr. Ding is an emerging researcher building a solid track record in pulmonary molecular biology, with demonstrated expertise in miRNAs, ion channel regulation, and translational potential in lung disease therapy.

Profile : Google scholar

Featured Publications

“Factors influencing the provision of public health services by village doctors in   Hubei and Jiangxi provinces,
China”

“Practical actions for fostering cross-disciplinary global health research: lessons from a narrative literature         review”

“Healthcare seeking behaviour among Chinese elderly”

“A cost-effectiveness analysis of three components of a syndromic surveillance system for the early warning of   epidemics in rural China”

“Qualitative study exploring lessons from Liberia and the UK for building a people-centred resilient health system response to COVID-19”